Objectives: The in vitro pharmacodynamics of silver(I) and silver(II) complexes of a polydiguanide ligand, chlorhexidine, were assayed to examine the value of the bactericidal endpoint as an alternative means of evaluating their antibacterial activities against burn wound pathogens.
Introduction
The toxicity of metallopharmaceuticals can often be aggravated by the toxic carrier molecules. Coordination of metal to non-toxic molecules could offer a solution for safe therapeutic applications of metal compounds. Biologically compatible molecules known to have minimal or no established in vivo toxicity, such as polydiguanides, may be excellent candidates for this purpose. Polycations like polydiguanides have widespread application as non-toxic disinfectants or additives. 1 -3 We are interested in the synthesis of silver polydiguanide complexes that have the potential to be used as a new class of antimicrobial agent, particularly for the topical treatment of burn and wound infections. Polydiguanides possess conjugate single and double bond systems and filled p-type delocalized orbitals suitable for higher valency silver complex formation. Recently, we reported the synthesis of highly monodispersed nanoparticles of a trivalent silver polydiguanide complex with high antibacterial efficacy. 4 However, they are difficult and expensive to produce in large quantities.
The quest for large-scale synthesis of new silver complexes with high antibacterial efficacy has prompted us to study the interaction of polydiguanide ligands with silver at different oxidation states.
For the first time, we report herein that monovalent and divalent silver polydiguanide complexes are useful antibacterial agents as they showed strong antibacterial activity against the tested Gram-positive and Gram-negative strains. The in vitro pharmacodynamics of these agents were also studied to examine the value of the bactericidal endpoint as an alternative means of evaluating their antibacterial activity against the tested species.
Materials and methods

Synthesis of the complexes
Ag(I)CHX was precipitated by neutralizing the pH of an acidic mixture of chlorhexidine (CHX) and AgNO 3 . Ag(II)CHX was synthesized by oxidizing silver(I) in the presence of CHX. The complex was precipitated from the feebly acidic or neutral medium. Details of the synthesis protocols and Fourier transform infra-red, 1 H-NMR and X-ray photoelectron spectra of the complexes (Figures S1 and S2) are available as Supplementary data at JAC Online (http://jac.oxfordjournals.org/).
Bacterial strains and culture conditions
Unless otherwise stated, the strains (see Table 1 ) were grown overnight in tryptic soy broth or agar (Difco Laboratories) at 378C under aerobic conditions. Propionibacterium acnes (ATCC 6919) inocula were cultured in brain heart infusion (BHI) broth or agar (Difco Laboratories) supplemented with 1% glucose (BHIG) for 48 h at 378C under anaerobic conditions.
Determination of MICs and MBCs
MICs were determined by the agar dilution method in BHI agar for P. acnes or in Mueller-Hinton (MH) agar (Difco Laboratories) for all other species. Plates were read after incubation at 378C for 48 h under anaerobic conditions for P. acnes, or for 24 h in air for all other species. MICs by the broth microdilution method were determined using MH broth (Difco Laboratories). P. acnes was grown in BHIG broth. Strains were cultured in 96-well microplates. Each well was supplemented with a range of concentrations of the active agents. Following a 24 h incubation in air or a 48 h incubation under anaerobic conditions at 378C, the MIC was determined as the lowest concentration that did not produce visual growth. The MBCs were determined by reinoculation of each growth in wells onto MH or BHI agar plates. After 24 or 48 h of incubation, the MBC was defined as the lowest concentration at which no growth was observed on the plate. All tests (in triplicate) were performed in line with CLSI (formerly NCCLS) guidelines. 5 
Study of killing kinetics
Stock solutions of the test agents were added to logarithmic-phase broth cultures of the test bacterial strains ( 10 5 -10 6 cfu/mL) to give concentrations equivalent to 0.25×, 1× and 4× MIC. Viable bacterial counts were determined at 0, 1, 3, 6 and 10 h after addition of the antimicrobial agents. The bactericidal endpoint is defined as a 3 log 10 (99.9%) decrease in cfu/mL. The experimental data were fitted to a non-linear exponential regression equation: C t ¼C 0 e 2Kt (C t , concentration of viable cells at time t; C 0 , concentration of starting inoculum; K, a constant). The time to achieve 50% (t 50 ) or 99.9% (t 99.9 ) growth reduction at each concentration tested was calculated from the K value. All tests were conducted in duplicate on two separate occasions.
Results
Antibacterial susceptibility tests
The MIC and MBC values of the test compounds are listed in Table 1 . The MIC values of Ag(I)CHX and Ag(II)CHX were much lower than those of CHX, AgNO 3 and silver sulfadiazine (AgSD). 6, 7 All test compounds appeared to be bactericidal with MBC/MIC ratios of 1 -4. The MICs determined by agar dilution methods were approximately twice those obtained by the broth dilution method.
Killing kinetics
The killing activity of Ag(I)CHX and Ag(II)CHX was faster than that of CHX and AgNO 3 at the MIC ( Figure 1a ). The bactericidal activity of Ag(I)CHX and Ag(II)CHX was faster (1 -3 h at 1× MIC) against four strains of Gram-negative bacteria; the reduction in cfu/mL was .3 log units (99.9%). However, at a 4× higher concentration the antibacterial efficacy of the tested agents was comparable, especially against the Gram-negative bacteria (Figure 1b) . The bactericidal endpoint was reached within 1 h of incubation. At the same concentration the killing activities of CHX and AgNO 3 against the Gram-positive bacteria tested were not as fast as the other two compounds tested. At a lower concentration (0.25× MIC) Ag(I)CHX inhibited the growth of Staphylococcus aureus for .10 h. However, for other species the effect was not sustained for more than 1 h [ Figure S3 , available as Supplementary data at JAC Online (http:// jac.oxfordjournals.org/)].
The relationship between the concentration of each antibacterial agent and the lethality rate (K value) for seven bacteria is represented in Figure 1 (c). While positive K values indicate growth, negative K values indicate killing. For Gram-positive bacteria the relationship between the concentration of the agents and their lethality was linear, clearly indicating a faster lethality rate at a higher concentration. The lethality rates of CHX and AgNO 3 were lower than those of Ag(I)CHX and Ag(II)CHX at the Pal et al. 
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MIC for all tested strains. At a higher concentration all agents appeared to have similar lethality rates against Gram-negative bacteria.
Killing of 50% of the Gram-negative bacteria tested and Enterococcus faecalis at 1× MIC was achieved within 2-12 min (Table 2 ). However, killing of 50% of S. aureus and Staphylococcus epidermidis, especially using AgNO 3 or CHX, required much longer incubation times. Faster killing was achieved using a higher concentration of the agents (t 50 , 1-20 min at 4× MIC). At 1× MIC t 99.9 values of AgNO 3 , Ag(I)CHX and Ag(II)CHX for the Gram-negative bacteria were much lower than those for Grampositive strains. Especially times required to reach the bactericidal endpoint of S. aureus and S. epidermidis were excessively long [7 - 19 h for AgNO 3 and 2 -12 h for Ag(I)CHX and Ag(II)CHX at 1× MIC]. At 4× MIC the bactericidal endpoint was reached within 1 h using Ag(I)CHX and Ag(II)CHX.
Discussion
The theoretical amount of silver ions that could be released from 1 g of Ag(I)CHX or Ag(II)CHX is 4× and 2× lower than that from 1 g of AgNO 3 and AgSD, respectively. The MICs determined using the agar dilution method were 2-fold higher than those obtained using the broth dilution method. The diffusing ability of the test compound in agar might have been limited compared with that in liquid broth. 8 The lower activity of AgNO 3 and AgSD compared with silver polydiguanide complexes in liquid broth can be attributed to the precipitation of AgCl, i.e. lower availability of silver in the supernatant solutions. We speculate that silver polydiguanides react more slowly with the chloride ions than AgNO 3 or AgSD in the growth medium. The contribution of the polydiguanide ligand, therefore, appears to be significant towards reducing the formation of AgCl in the broth solution. This is an excellent property considering the potential in vivo application of silver polydiguanide complexes.
Assuming that the killing process could be described by a firstorder kinetic rate constant (K) the rate of bacterial removal was quantified from the experimental studies. The rate constant was taken to be invariable with respect to time and uniform among the bacterial population. Previously, antifungal activities of several antibiotics were also adequately modelled as a first-order kinetic process. 9, 10 Our investigation identified the time required for the bactericidal activity (t 50 to t 99.9 ) for each strain ( Table 2) . The inclusion of a range of concentrations of active agents yielded a large number of curves, which ruled out an easy comparison of the results. Calculation of the K value reduced the time -kill curve obtained for each concentration to one point, facilitating visualization of the killing pattern (Figure 1c) . The difference in the antibacterial efficacy of the agents towards Gram-positive or Gram-negative pathogens, which was seemingly not pronounced from the MIC evaluations, became evident from the time -kill study. The time required to reach the bactericidal endpoint for the Gram-positive strains was much longer than that required for the Gram-negative strains.
The lethality rates of silver polydiguanides were 2× to 8× faster than those of CHX or AgNO 3 at 1 -4× MIC. The superior antibacterial activity of silver complexes and their faster removal kinetics probably reveal the role of the polydiguanide ligand and of highly charged species that are efficiently dissolved in the growth medium. Unlike ionic compounds or simple silver salts the complex is not very likely to dissociate into constituent species in solution. We speculate that the antibacterial effect of the synthesized compounds is more of a synergistic effect of silver and CHX rather than a simple additive effect of the individual components. The higher positive charge density of biguanide residues in CHX can be attributed to the relative electron withdrawing effect of two symmetrically positioned p-chlorophenyl moieties. Thus, an explanation for the higher antibacterial activity of silver polydiguanides could be based on the fact that polydiguanide ligand in these complexes serves as an improved carrier, favouring the interaction of the complexes with the negatively charged bacterial cell surface and enhancing their cellular uptake, leading to faster cell death. However, it is imperative that the mode of action of these complexes be explored more rigorously. A detailed study of the structure-antibacterial activity relationship of silver polydiguanides and their mode of antibacterial action is the subject of ongoing research.
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